BCM
Bayesian Capital Management’s Iovance Biotherapeutics IOVA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-59,321
| Closed | -$198K | – | 710 |
|
|
2025
Q1 | $198K | Buy |
+59,321
| New | +$198K | 0.03% | 498 |
|
|
2024
Q4 | – | Sell |
-184,400
| Closed | -$1.73M | – | 835 |
|
|
2024
Q3 | $1.73M | Buy |
184,400
+137,200
| +291% | +$1.29M | 0.2% | 149 |
|
|
2024
Q2 | $379K | Sell |
47,200
-104,500
| -69% | -$838K | 0.04% | 443 |
|
|
2024
Q1 | $2.25M | Buy |
151,700
+116,300
| +329% | +$1.72M | 0.21% | 131 |
|
|
2023
Q4 | $288K | Buy |
35,400
+21,000
| +146% | +$171K | 0.03% | 527 |
|
|
2023
Q3 | $65.5K | Sell |
14,400
-69,020
| -83% | -$314K | 0.01% | 629 |
|
|
2023
Q2 | $587K | Buy |
+83,420
| New | +$587K | 0.06% | 373 |
|
|
2022
Q3 | – | Sell |
-107,782
| Closed | -$1.19M | – | 856 |
|
|
2022
Q2 | $1.19M | Buy |
+107,782
| New | +$1.19M | 0.22% | 121 |
|